The AHA yesterday filed a declaration supporting other organizations seeking a temporary restraining order and preliminary injunction to prevent the Centers for Medicare & Medicaid Services from cutting under its Most Favored Nation Model payments for certain Medicare Part B drugs and biologicals to no more than the lowest price that drug manufacturers receive in other similar countries.

The declaration raised both procedural and substantive concerns, including the lack of proper notice for a rule of this magnitude, the harm the rule’s implementation would likely do to patients, particularly in rural areas, and the inability for providers to negotiate new agreements with drug companies in just three weeks.

Under an interim final rule issued last month, the model will become mandatory Jan. 1 for most hospitals. The Pharmaceutical Research and Manufacturers of America, Association of Community Cancer Centers and others last week filed a federal lawsuit seeking to enjoin enforcement of the rule and declare it unconstitutional and invalid.

Related News Articles

Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
The White House May 12 released an executive order to reduce prescription drug costs by allowing consumers to make direct purchases from drug manufacturers at…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…